SAKAGUCHI JEFFREY B
Known title: DirectorCIK: 0001506988
Associated companies
Transaction History
| TBI | ▲ Buy | Grant | 35,733 | $0 | 2/20/2026 | View on chart |
| TBI | ▲ Buy | Grant | 22,241 | $0 | 2/21/2025 | View on chart |
| TBI | ▲ Buy | Grant | 12,342 | $0 | 2/23/2024 | View on chart |
| TBI | ▼ Sell | Gift | 358 | $0 | 12/1/2023 | View on chart |
| TBI | ▲ Buy | Grant | 8,738 | $0 | 2/3/2023 | View on chart |
| TBI | ▼ Sell | Gift | 485 | $0 | 11/29/2022 | View on chart |
| TBI | ▲ Buy | Grant | 6,332 | $0 | 2/4/2022 | View on chart |
| TBI | ▼ Sell | Gift | 381 | $0 | 11/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TrueBlue (TBI) Gains on Energy and Data Center Outlook
TrueBlue is highlighted as a beneficiary of ongoing energy infrastructure projects and the expansion of data centers, according to a recent Seeking Alpha piece. The stock also rose about 7.9% in recent trading, reflecting investor interest in those themes. The move comes as the shares trade near the middle of their 52‑week range with an RSI close to 50, and the price is above a well‑tested support level around $3.83.
TrueBlue (TBI) Gains on Energy and Data Center Outlook. TrueBlue is highlighted as a beneficiary of ongoing energy infrastructure projects and the expansion of data centers, according to a recent Seeking Alpha piece. The stock also rose about 7.9% in recent trading, reflecting investor interest in those themes. The move comes as the shares trade near the middle of their 52‑week range with an RSI close to 50, and the price is above a well‑tested support level around $3.83.